Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Categories
formulations
Marksans Pharma Ltd Q4FY24; 6% fall in Profits
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q4FY24 of
Torrent Pharmaceuticals Ltd Q4FY24; 56% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Sequent Scientific Ltd Q4FY24; 1% fall in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Themis Medicare Ltd Q2FY24; 39% fall in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
Wockhardt Ltd Q2FY24; 11% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
A Primer on India’s Oldest Pharma Company Ft Alembic Pharmaceuticals
“The company grew in all the business segments with India outperforming the market with 9% growth, Ex US generics grew 46%, API
Syncom Formulations (India) Ltd Q1FY24; 10% rise in Profits
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products.
Themis Medicare Ltd Q1FY24; 6% rise in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
Lupin Q2FY23 results out: Net profit rises more than 100%
Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the